Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/05/2003EP1358869A1 Biologically active compounds for the modificaton of bodily odours
11/05/2003EP1358857A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
11/05/2003EP1358485A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358348A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358338A2 Human protein kinase n-like polypeptide and uses thereof
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1358212A1 Methods for the synthesis of a modified hemoglobin solution
11/05/2003EP1358211A2 Methods for regulating the kinase domain of ephb2
11/05/2003EP1358210A2 Adhesion molecules
11/05/2003EP1358209A2 Crystallization of igf-1
11/05/2003EP1358208A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358204A1 Tripeptide derivatives for the treatment of neurodegenerative diseases
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1358200A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
11/05/2003EP1358199A2 Antisense modulation of src-1 expression
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358163A1 Melanocortin receptor agonists
11/05/2003EP1357978A2 Hematopoietic stem cell gene therapy
11/05/2003EP1357974A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
11/05/2003EP1357973A2 Gssp4 polynucleotides and polypeptides and uses thereof
11/05/2003EP1357937A2 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
11/05/2003EP1357936A1 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES
11/05/2003EP1357935A2 Method of reducing side effects of chemotherapy in cancer patients
11/05/2003EP1357934A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity
11/05/2003EP1357933A2 Modified erythropoietin (epo) with reduced immunogenicity
11/05/2003EP1357932A1 Crystal modification of a cyclic depsipeptide having improved strength
11/05/2003EP1357931A2 Keratinocyte growth factor-2
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357914A2 Treatment of ppar mediated diseases
11/05/2003EP1357901A2 Process
11/05/2003EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
11/05/2003EP1357897A2 Delivery of biologically active agents
11/05/2003EP1357828A2 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1150726B1 Highly-mineralized osteogenic sponge compositions, and uses thereof
11/05/2003EP1061942B1 Topical composition containing human epidermal growth factor
11/05/2003EP1051194B9 Process for making absorbable microparticles
11/05/2003EP1007034B1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
11/05/2003EP0994945B1 Smad-interacting polypeptides and their use
11/05/2003EP0981362B1 Use of glp-2 agonists enhancing functioning of the upper gastrointestinal tract
11/05/2003EP0971703B9 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
11/05/2003EP0968001B1 Method for the detection and localization of malignant human pancreatic tumours
11/05/2003EP0938506B1 Immunoglobulin superfamily domains and fragments with increased solubility
11/05/2003EP0796867B1 Peptide, bronchodilator and blood flow ameliorant
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0699073B1 xenogeneic transplantation
11/05/2003EP0656366B1 Iron-lactoferrin combination and process for producing the same
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0654078B1 A thrombin blood fraction for use in a medical procedure
11/05/2003EP0651801B1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
11/05/2003EP0601106B2 Morphogen-induced modulation of inflammatory response
11/05/2003EP0550625B1 Bmp-5 derivatives
11/05/2003EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454260A Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454254A Purging of cells using viruses
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454214A Modified peptides with increased potency
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454205A Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
11/05/2003CN1454104A Needle for intradermal delivery of substances having penetration limiting means
11/05/2003CN1454098A Depletion method of blood plasma ascorbate
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454090A Compositions and methods for improving cardiovascular function
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453361A Construction method of virus as anticancer targeting adjustable gene
11/05/2003CN1453356A Natto kinase purifying process and its freeze dried powder for injection
11/05/2003CN1453293A Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate
11/05/2003CN1453291A Synthesis and use of organic polypeptide compound
11/05/2003CN1453038A Application of agrose in preparing medicine for prostate hyperplosia
11/05/2003CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone
11/05/2003CN1126758C Prepn. of blood coagulation factor IX compound
11/05/2003CN1126567C Stalilized composition for NGF and reagent box and preparing process thereof
11/05/2003CN1126566C Luteinizing hormone releasing hormone antagonist and use for medicine preparation for treating prostate hypertrophy and prostate cancer
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/04/2003US6642433 Nucleic acid construct comprising a promoter, marker and nucleotide sequence; producing animals with decreased gene expression and increased survival when infected with hepatitis virus; allograph rejection, fetal loss inflammatory bowel
11/04/2003US6642411 Compounds and compositions for delivering active agents
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642368 Programmed cell death and caspase-12
11/04/2003US6642363 Bonded to a peptide which promotes cell adhesion and growth; use in drug delivery, cell transplantation and tissue engineering
11/04/2003US6642362 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/04/2003US6642361 Polypeptide for use in genration of silk
11/04/2003US6642360 Secreted polypeptides that stimulate release of proteoglycans from cartilage
1 ... 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 ... 3163